Związki koordynacyjne rutenu jako leki w nowoczesnej terapii przeciwnowotworowej

Abstract

The study of metal coordination compounds for the treatment of cancer has resulted in the identification of some unique properties of ruthenium complexes as antitumour agents. Among these group two of them, NAMI-A and KP1019 have entered the clinical trials with patients. The studies showed that NAMI-A inhibits the formation of metastases and KP1019 demonstrates exciting anticancer activities especially in colorectal carcinoma. As well as these two compounds, organometallic ruthenium-based complexes RM175, RAPTA-T, RDC11 and DW1/2 are very promising in the antitumour therapy.